P/36/2011
Key facts
| Active substance |
|
| Therapeutic area |
Oncology
|
| Decision number |
P/36/2011
|
| PIP number |
P/36/2011
|
| Pharmaceutical form(s) |
Solution for injection
|
| Condition(s) / indication(s) |
Prevention of chemotherapy induced neutropenia
|
| Route(s) of administration |
Subcutaneous use
|
| Contact for public enquiries |
Teva Pharmaceuticals Europe B.V
|
| Decision type |
RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s)
|